OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

Charity registration number 1171659 (England and Wales)

THE BRITISH SOCIETY FOR PARASITOLOGY

ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

THE BRITISH SOCIETY FOR PARASITOLOGY

LEGAL AND ADMINISTRATIVE INFORMATION

Trustees Prof H Price (President)
Prof M Llewellyn (Honorary General
Secretary)
Prof P Lamberton (Honorary
Treasurer)
Dr J LaCourse (Meeting Secretary)
Dr D Xia (Ordinary Member)
Dr N Pionnier (Ordinary Member)
Dr V Yurchenko (Ordinary Member)
Dr V Marugan-Hernandez (Ordinary
Member)
J Archer (Ordinary Member)
Dr G Ebiloma (Ordinary Member)
Dr G Oldrieve (Ordinary Member)
Dr R Shears (Ordinary Member) (Appointed 1 April 2025)
Prof M Barrett OBE (Vice President) (Appointed 4 April 2025)
Dr R Morphew (Ordinary Member) (Appointed 1 April 2025)
Charity registration England and Wales 1171659
Principal address 87 Gladstone Street
Bedfordshire
MK41 7RS
Independent examiner Katie Squire ACA, Anova
2 Piries Place
Horsham
West Sussex
RH12 1EH

THE BRITISH SOCIETY FOR PARASITOLOGY

CONTENTS

Page
Trustees' report 1 - 6
Independent examiner's report 7
Statement of financial activities 8
Balance sheet 9
Notes to the financial statements 10 - 18

THE BRITISH SOCIETY FOR PARASITOLOGY

TRUSTEES' REPORT

FOR THE YEAR ENDED 31 DECEMBER 2025

The Council of the BSP presents its annual report and financial statements for the year 1 January 2025 to 31 December 2025.

The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the Society's governing document, the Charities Act 2011 and “Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)” (as amended for accounting periods commencing from 1 January 2016).

Objectives and activities

The Society’s objectives are to advance the practice and study of Parasitology by facilitating contact between persons interested in the discipline, and to disseminate knowledge and information relating to Parasitology and the work of the Society. In furtherance of these objectives, and only these, we undertake the activities that are outlined in Note 4 of the Memorandum of Association.

Public benefit entity

The charity operates as a public benefit entity and the trustees have paid due regard to guidance issued by the Charity Commission, including guidance on the Public Benefit requirement under the Charities Act 2011, in deciding what activities the Society should undertake.

Reference and administrative details

The Society was incorporated as a charitable company in 1998 (Company Number 3530933). On the 22 March 2017, this charity was closed and the assets of the Society transferred to a new Charitable Incorporated Organisation (1171659). The Society is administered by the Secretariat, Fuller Solutions, of 87 Gladstone Street, Bedford MK41 7RS.

THE BRITISH SOCIETY FOR PARASITOLOGY

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

Achievements and performance Scientific meetings

Joint Parasitology Spring Meeting (Wurzburg)

The spring meeting this was held in conjunction with both the German Society for Parasitology and the Swiss Society for Tropical Medicine and Parasitology. The venue was the University of Wurzburg hosted by Professor Markus Engstler. The meeting was a huge success with one day of satellite meetings on the Physics of Parasitology amongst others. Followed by three days of Spring meeting. All parties considered the event a huge success.

Prize winners:

2025 Annual General Meeting

The 2025 AGM took place at the annual meeting and was quorate. The annual accounts and officer reports were accepted by the membership.

Dr R Morphew and Dr Rebecca Shears were elected Trustees.

CA Wright Medal Recipient Prof. Lilach Sheiner and President’s Medal Recipient Sara Silva Pereira

Membership of the Society

At time of preparing this report (28 March 2026), the Society has 985 'Ordinary Members', 1114 'LMIC Concession Members' from low and middle income counties, and 53 active ‘Honorary Members’.

The current annual fee for ‘Ordinary’ membership is £75, whilst the annual ‘Student, Unwaged, and Retired’ membership fee is £25.

THE BRITISH SOCIETY FOR PARASITOLOGY

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

BAVP 2025 annual conference in association with the BSP

No Autumn Symposium was held instead we ran a joint meeting with the British Association for Veterinary Parasitology (BAVP) whose members are also often members of the BSP. The BAVP is a smaller and less well resourced society so the decision was made to support their annual meeting both technically and financially. The meeting was a success with 57 attendees.

Trypanosomiasis and Leishmaniasis Seminar 2025

This year we held a five day seminar in Ceske Budejovice, Czechia at the Clarion Hotel. This meeting was hosted by the University of South Bohemia and the Czech Academy of Science. In addition, a celebration was held for Prof Alan Fairlamb as he retired this year.

Local Organisers: Zíková Alena, Paris Zdeněk pictured along with Český Krumlov a world heritage site visited by the meeting.

Equality and diversity

The council stipulates that all bids for BSP-endorsed meetings should contain provision for childcare and be available online to facilitate diversity of attendance. The BSP created an Equality and Diversity session, which ran successfully and is now institutionalised for future annual meetings. The meeting was hybrid, enabling considerable attendance from LMIC members who otherwise might not have been able to attend.

Financial review

Income

BSP income consists of donations and legacies, charitable activity, and investment income.

Donations and legacies

In 2025 the BSP received £23,497 in membership subscriptions (2024: £24,472), and £11,423 in royalties and sponsorships (2024: deducted £2,500 from a debt previously owed in sponsorship). Thus in 2025, the total donations and legacies received were £34,920 (2024: £21,972).

Although in recent years the amount of sponsorship has dropped due to the ending of a long-term Cambridge University Press (CUP) sponsorship, this has now been replaced by a new agreement with Elsevier.

Charitable activity

Meeting income, which includes registration fees and sponsorship, is counted as a charitable activity.

In 2025, the BSP held two meetings, the Joint meeting with the German and Swiss Societies in Wurzburg, Germany and a Tryp/Leish Symposium in Czechia (both hybrid in-person and on-line format.

In addition, the BSP actively supported the BAVP annual conference with technical and financial support (The society has many members of the BVAP in its ranks). For 2025, meeting income was £74,257 (2024: £111,443).

Investment income

In 2025 the BSP received £12,228 income from the investment portfolio in the form of interest and dividends (2024: £11,713).

Income summary

In 2025, the society’s total income was £121,405 (2024: £145,128).

Expenditure

Expenditure includes the cost of running scientific meetings and secretariat costs, support costs, grants (student travel awards and the International Training and Fieldwork Award (ITFA)).

Meetings expenditure

In 2025, meeting expenditure was £90,125 (2024: £102,532), with 50% of Secretariat fees charged to the meeting expenditure.

THE BRITISH SOCIETY FOR PARASITOLOGY

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

Support costs

Support costs include day-to-day office costs, banking and information technology charges, insurance and audits. For 2025, support costs were £41,248 (2024: £43,247), with 50% of Secretariat costs charged to the support costs.

Grants

Grant funding of activities include the Student Travel Awards and the ITFA. In 2025, the BSP grant funding was £11,300 (2024: £8,033).

Expenditure Summary

In 2025, the society’s total expenditure was £142,673 (2024: £153,812).

Investments

On the 31st December 2025, the value of the society’s investments with Brewin Dolphin was £550,519 (2024: £570,099), a decrease of £19,580 in investment value.

The net gain would have been just over £20,000 for 2025.

Movements

Due to the changes in inflation and economic poor performance in meeting from Covid onwards, along with Joint Parasitology generating no income, we decided to move £40,000 of assets from our investment account into our current account. This was to deal with these shortfalls and the cash flow issues that arise from this environment.

The impact is that the investment figures should be seen in the light of this movement. We expect the performance would be positive in terms of our investment assets if this movement had not occurred. We intend to return at least £20,000 to the investment account after the 2026 meetings.

Overall financial summary

In 2025, the society’s total income was £121,405 (2024: £145,128) and total expenditure was £142,673 (2024: £153,812), resulting in an operating deficit of £21,268 (2024: £8,684).

This operating deficit has been impacted by an increase in the value of the society’s investments, contributing to a surplus of £9,204. BSP’s total investment assets, however when all assets (investments, income, depreciation and particularly money in current bank account) are assessed the current General funds are £633,557 (2024: £624,354).

It is expected that the society’s investments will provide an increased investment return in subsequent years. The significant point is that the society received no income for the joint meeting, whilst they normally make a profit on the annual spring meetings. However, this loss was considered worthwhile for an occasional year, due to the wider scientific outreach and networking opportunities that it gave the BSP members.

Reserves policy

It is the policy of the Society that unrestricted funds which have not been designated for a specific use should be maintained at a level equivalent to between three and six month’s expenditure.

The trustees consider that reserves at this level will ensure that, in the event of a significant drop in funding, they will be able to continue the Society’s current activities while consideration is given to ways in which additional funds may be raised. This level of reserves has been maintained throughout the year.

THE BRITISH SOCIETY FOR PARASITOLOGY

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

Structure, governance and management

The Memorandum and Articles of Association of the Society govern the charitable incorporated organisation.

Management of the Society’s affairs is vested in its Council, members of which are trustees of the charity.

Members of Council are recruited from the membership of the Society by nomination by their peers. Where there are several candidates for vacancies, a ballot is held. Honorary Officers are elected by Council from those persons already duly elected as trustees in accordance with the Articles.

The appointment of trustees and election of Honorary Officers is subject to the approval of members at the next following AGM. Council members normally serve for three years from election/appointment, except the President and Vice President, who serve for two years. The post of President is filled by the retiring Vice President without any requirement for approval by the members in general meeting. The society is committed to maintaining a diversity in the council to best represent the diverse membership from which it is composed.

The processes are detailed in the Memorandum and Articles of Association, copies of which are available from the Society secretariat on request (https://bsp.uk.net).

The Council of the Society meets regularly during the year including for the Annual General Meeting at which business requiring the approval of the Society membership is presented and the independently examined accounts for the year are formally approved.

The trustees who served during the year and up to the date of signature of the financial statements were:

Prof J V Hamilton (former President) (Resigned 3 April 2025) Prof H Price (President) Prof M Llewellyn (Honorary General Secretary) Prof P Lamberton (Honorary Treasurer) Dr J Pachebat (former Temp Honorary Treasurer) (Resigned 3 April 2025) Dr J LaCourse (Meeting Secretary) Dr E Briggs (Ordinary Member) (Resigned 3 April 2025) Dr D Xia (Ordinary Member) Dr P McCusker (Ordinary Member) (Resigned 3 April 2025) Dr C Tiengwe (Ordinary Member) (Resigned 3 April 2025) Dr J B Power (Ordinary Member) (Resigned 3 April 2025) Dr N Pionnier (Ordinary Member) Dr V Yurchenko (Ordinary Member) Dr V Marugan-Hernandez (Ordinary Member) J Archer (Ordinary Member) Dr G Ebiloma (Ordinary Member) Dr G Oldrieve (Ordinary Member) Dr R Shears (Ordinary Member) (Appointed 1 April 2025) Prof M Barrett OBE (Vice President) (Appointed 4 April 2025) Dr R Morphew (Ordinary Member) (Appointed 1 April 2025)

In April 2025 Ordinary Member and Student Representative were elected to join Council.

Over the year there were three meetings of Council convened with all meetings held as a hybrid meetings with both face to face and online attendees.

No trustees received any remuneration for their services during this period in accordance with note 5 of the Memorandum of Association.

Trustees claimed £1,577 in expense (2024: £564) due to the location of the AGM.

THE BRITISH SOCIETY FOR PARASITOLOGY

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

The trustees' report was approved by the Board of Trustees.

.............................. Prof H Price (President) Trustee Dated: .........................

.............................. Prof P Lamberton (Honorary Treasurer) Trustee Dated:.........................

THE BRITISH SOCIETY FOR PARASITOLOGY

INDEPENDENT EXAMINER'S REPORT

TO THE TRUSTEES OF THE BRITISH SOCIETY FOR PARASITOLOGY

I report to the trustees on my examination of the financial statements of The British Society for Parasitology (the Society) for the year ended 31 December 2025.

Responsibilities and basis of report

As the trustees of the Society you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities Act 2011.

I report in respect of my examination of the Society’s financial statements carried out under section 145 of the 2011 Act. In carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent examiner's statement

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.

Katie Squire ACA, Anova

2 Piries Place Horsham West Sussex RH12 1EH Date: ............................

THE BRITISH SOCIETY FOR PARASITOLOGY

STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 DECEMBER 2025

Unrestricted Unrestricted
funds funds
2025 2024
Notes £ £
Income from:
Donations and legacies 3 34,920 21,972
Charitable activities 4 74,257 111,443
Investments 5 12,228 11,713
Total income 121,405 145,128
Expenditure on:
Charitable activities 6 142,673 153,812
Total expenditure 142,673 153,812
Net gains/(losses) on investments 12 30,472 19,092
Net income and movement in funds 9,204 10,408
Reconciliation of funds:
Fund balances at 1 January 2025 624,353 613,945
Fund balances at 31 December 2025 633,557 624,353

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

THE BRITISH SOCIETY FOR PARASITOLOGY

BALANCE SHEET

AS AT 31 DECEMBER 2025

Notes
Fixed assets
Intangible assets
14
Tangible assets
15
Investments
16
Current assets
Debtors
17
Cash at bank and in hand
Creditors: amounts falling due within
one year
18
Net current assets
Total assets less current liabilities
The funds of the Society
Unrestricted funds
20		 2025
£
3,765
92,390
96,155
(15,579)		 £
1,800
662
550,519
552,981
80,576
633,557
633,557
633,557		 2024
£
3,163
53,476
56,639
(7,553)		 £
4,200
968
570,099
575,267
49,086
624,353
624,353
624,353

The financial statements were approved by the trustees on .........................

.............................. .............................. Prof H Price (President) Prof P Lamberton (Honorary Treasurer) Trustee Trustee

THE BRITISH SOCIETY FOR PARASITOLOGY

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

1 Accounting policies

Charity information

The British Society for Parasitology is a Charitable Incorporated Organisation and the principal address is 87 Gladstone Street, Bedfordshire, MK41 7RS.

1.1 Accounting convention

The financial statements have been prepared in accordance with the Society's governing document, the Charities Act 2011 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)". The Society is a Public Benefit Entity as defined by FRS 102.

The Society has taken advantage of the provisions in the SORP for charities applying FRS 102 Update Bulletin 1 not to prepare a Statement of Cash Flows.

The financial statements are prepared in sterling, which is the functional currency of the Society. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2 Going concern

At the time of approving the financial statements, the trustees have a reasonable expectation that the Society has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3 Charitable funds

Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.

1.4 Incoming resources

Income is recognised when the Society is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

Donations are recognised once the Society has been notified of the donation, unless performance conditions require deferral of the amount.

1.5 Resources expended

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that an economic outflow will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all costs related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Grants offered subject to conditions which have not been met at the year end date are noted as a commitment but not accrued as expenditure.

THE BRITISH SOCIETY FOR PARASITOLOGY

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

1 Accounting policies

(Continued)

1.6 Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Website development

25% on cost

1.7 Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computer equipment 25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.

1.8 Fixed asset investments

Fixed asset investments are initially measured at transaction price excluding transaction costs, and are subsequently measured at fair value at each reporting date. Changes in fair value are recognised in net income/(expenditure) for the year. Transaction costs are expensed as incurred.

1.9 Impairment of fixed assets

At each reporting end date, the Society reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

1.10 Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.11 Financial instruments

The Society has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Society's balance sheet when the Society becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

THE BRITISH SOCIETY FOR PARASITOLOGY

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

1 Accounting policies

(Continued)

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

2 Critical accounting estimates and judgements

In the application of the Society’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3 Donations and legacies

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Membership subscriptions 23,497 24,472
Royalties and sponsorship 11,423 (2,500)
34,920 21,972

4 Income from charitable activities

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Income from meeting activities 74,257 111,443

THE BRITISH SOCIETY FOR PARASITOLOGY

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

5 Income from investments

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Other income 12,211 11,583
Interest receivable 17 130
12,228 11,713

6 Expenditure on charitable activities

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Direct costs
Meeting costs 90,125 102,532
Grant funding of activities (see note 7) 11,300 8,033
Share of support and governance costs (see note 8)
Support 41,248 43,247
142,673 153,812
Analysis by fund
Unrestricted funds 142,673 153,812

7 Grants payable

During the year total grants paid as part of the charitable activities of the Society amounted to £11,300 (2024: £8,033 ).

THE BRITISH SOCIETY FOR PARASITOLOGY

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

8 Support costs

Support costs
Support
costs
Governance
costs
£
£
Depreciation
2,706
-
Bank and credit card charges
2,482
-
Insurance
991
-
Computer software expenses
4,887
-
Affiliations
850
-
Legal and professional fees
5,510
-
Independent examiner's remuneration
2,976
-
Trustees' expenses
1,747
-
Secretariat fees
19,099
-
Committee meeting expenses
-
-
41,248
-
Analysed between
Charitable activities
41,248
-		 2025Support costs Governance
costs
£
£
£
2,706
2,655
-
2,482
2,330
-
991
985
-
4,887
8,211
-
850
850
-
5,510
5,387
-
2,976
2,724
-
1,747
564
-
19,099
19,108
-
-
433
-
41,248
43,247
-
41,248
43,247
-		 2024
£
2,655
2,330
985
8,211
850
5,387
2,724
564
19,108
433
43,247
43,247

THE BRITISH SOCIETY FOR PARASITOLOGY

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

9 Net movement in funds 2025 2024
£ £
The net movement in funds is stated after charging/(crediting):
Fees payable for the independent examination of the charity's financial
statements 2,975 2,850
Depreciation of owned tangible fixed assets 306 255
Amortisation of intangible assets 2,400 2,400

10 Trustees

None of the trustees (or any persons connected with them) received any remuneration or benefits from the Society during the year.

During the year the trustees claimed expenses for travel and subsistence totalling £1,577 (2024: £564).

11 Employees

The average monthly number of employees during the year was:

2025 2024
Number Number
Total - -

There were no employees whose annual remuneration was more than £60,000.

12 Gains and losses on investments

Unrestricted Unrestricted
funds funds
2025 2024
Gains/(losses) arising on: £ £
Revaluation of investments 30,472 19,092

13 Taxation

The charity is exempt from taxation on its activities because all its income is applied for charitable purposes.

THE BRITISH SOCIETY FOR PARASITOLOGY

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

14 Intangible fixed assets
Website development
£
Cost
At 1 January 2025 and 31 December 2025 9,600
Amortisation and impairment
At 1 January 2025 5,400
Amortisation charged for the year 2,400
At 31 December 2025 7,800
Carrying amount
At 31 December 2025 1,800
At 31 December 2024 4,200
15 Tangible fixed assets
Computer
equipment
£
Cost
At 1 January 2025 1,223
At 31 December 2025 1,223
Depreciation and impairment
At 1 January 2025 255
Depreciation charged in the year 306
At 31 December 2025 561
Carrying amount
At 31 December 2025 662
At 31 December 2024 968

THE BRITISH SOCIETY FOR PARASITOLOGY

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

16 Fixed asset investments

Cost or valuation
At 1 January 2025
Additions
Valuation changes
Equalisations and adjustments
Accrued income
Disposals
At 31 December 2025
Carrying amount
At 31 December 2025
At 31 December 2024
Investments at fair value comprise:
UK equities and other investments
Overseas equities and other investments
UK fixed interest securities
17
Debtors
Amounts falling due within one year:
Prepayments and accrued income
18
Creditors: amounts falling due within one year
Notes
Deferred income
19
Accruals		 Listed
investments
£
570,099
74,512
28,889
1,291
505
(124,777)
550,519
550,519
570,099
2025
2024
£
£
99,383
114,038
336,792
431,783
114,344
24,278
550,519
570,099
2025
2024
£
£
3,765
3,163
2025
2024
£
£
7,900
-
7,679
7,553
15,579
7,553

THE BRITISH SOCIETY FOR PARASITOLOGY

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

19
Deferred income
Other deferred income
Deferred income is included in the financial statements as follows:
Deferred income is included within:
Current liabilities
Movements in the year:
Deferred income at 1 January 2025
Resources deferred in the year
Deferred income at 31 December 2025		 2025
£
7,900
2025
£
7,900
-
7,900
7,900		 2024
£
-
2024
£
-
-
-
-

20 Unrestricted funds

The unrestricted funds of the charity comprise the unexpended balances of donations and grants which are not subject to specific conditions by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes.

At 1
General funds
Previous year:
At 1
General funds		 January
2025
Incoming
resources
Resources
expended
Gains and
losses
At 31
December
2025
£
£
£
£
£
624,353
121,405
(142,673)
30,472
633,557
January
2024
Incoming
resources
Resources
expended
Gains and
losses
At 31
December
2024
£
£
£
£
£
613,945
145,128
(153,812)
19,092
624,353

21 Related party transactions

Trustees were reimbursed for out-of-pocket expenses incurred in carrying out their duties. These amounts are disclosed in the Trustees’ expenses note.

There were no other related party transactions during the year that require disclosure.